Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States

Annals of the American Thoracic Society

Volumn 13, Issue 6, 2016, Pages 803-810

  Kumbhare, Suchit ^a   Pleasants, Roy ^b   Ohar, Jill A ^c   Strange, Charlie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral Risk Factor Surveillance System; Chronic obstructive pulmonary disease; Chronic obstructive pulmonary disease asthma overlap syndrome; Comorbidity; Hospitalization

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE CONTROL; EXERCISE; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBSERVATIONAL STUDY; PREVALENCE; SMOKING; SPIROMETRY; TELEPHONE INTERVIEW; UNITED STATES; AGE DISTRIBUTION; BODY MASS; COMORBIDITY; COMPLICATION; HEALTH SURVEY; HOSPITALIZATION; MIDDLE AGED; RISK FACTOR; SELF REPORT; SEX RATIO; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGED; ASTHMA; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SELF REPORT; SEX DISTRIBUTION; SMOKING; UNITED STATES;

EID: 84989322200     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201508-554OC     Document Type: Article

References (51)

1. Elias J. The relationship between asthma and COPD: lessons from transgenic mice. Chest 2004;126:111S-116S. [Discussion, pp. 159S-161S.]
2. Nakawah MO, Hawkins C, Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J Am Board Fam Med 2013;26:470-477
3. Education NA, Program P; National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120:S94-S138
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276
5. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999;14: 892-896
6. Vonk JM, Jongepier H, Panhuysen CIM, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58:322-327
7. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001;164:744-748
8. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005;11:7-13
9. Banerji A, Clark S, Afilalo M, Blanda MP, Cydulka RK, Camargo CA Jr. Prospective multicenter study of acute asthma in younger versus older adults presenting to the emergency department. J Am Geriatr Soc 2006;54:48-55
10. Miravitlles M, Andreu I, Romero Y, Sitjar S, Altés A, Anton E. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract 2012;62:e68-e75
11. Global Initiative for Asthma. Diagnosis of diseases of chronic airflow limitation: asthma COPD and asthma-COPD overlap syndrome (ACOS). 2014 [accessed 2015 Jul 12]. Available from: http://www. goldcopd.org/uploads/users/files/AsthmaCOPDOverlap.pdf
12. Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. Plos One 2013;8:e62985
13. Menezes AMB, Montes Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JR, Valdivia G, Talamo C; PLATINO Team. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPDasthma. Chest 2014;145:297-304
14. Chung JW, Kong KA, Lee JH, Lee SJ, Ryu YJ, Chang JH. Characteristics and self-rated health of overlap syndrome. Int J Chron Obstruct Pulmon Dis 2014;9:795-804
15. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127
16. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, Kioumis I, Pitsiou G, Pataka A, Tsakiridis K, Arikas S, Mpakas A, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis 2014;6:S146-S151
17. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www. goldcopd.org/uploads/users/files/GOLD-Report-2015-Feb18.pdf
18. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo) 2011;2011:861926
19. Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, Morrissey BM, Albertson TE. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol 2013;6:197-219
20. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al.; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-750
21. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232
22. de Marco R, Accordini S, Cerveri I, Corsico A, AntóJM, Künzli N, Janson C, Sunyer J, Jarvis D, Chinn S, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-39
23. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansal SK. Asthma in the elderly: underperceived, underdiagnosed and undertreated: a community survey. Respir Med 1998;92:573-577
24. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128:2099-2107
25. Lindner K, Panaszek B, Machaj Z. Asthma in the elderly [in Polish]. Pol Arch Med Wewn 2007;117:350-354
26. Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001;119:720-725
27. Nascimento OA, Camelier A, Rosa FW, Menezes AMB, Pérez-Padilla R, Jardim JR; Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Group. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res 2007;40:887-895
28. Andersén H, Lampela P, Nevanlinna A, Säynäjäkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 2013;7:342-346
29. Yawn BP, Yawn RA. Immunosuppressive and anti-inflammatory consequences of ICS therapy in COPD: the epidemiology perspective. Respiratory Drug Delivery. 2014;1:25-38
30. Dimov D, Tacheva T, Koychev A, Ilieva V, Prakova G, Vlaykova T. Obesity in Bulgarian patients with chronic obstructive pulmonary disease. Chron Respir Dis 2013;10:215-222
31. Çolak Y, Marott JL, Vestbo J, Lange P. Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study. COPD 2015;12:5-13
32. Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax 2015;70:683-691
33. Marseglia L, Manti S, D'Angelo G, Nicotera A, Parisi E, Di Rosa G, Gitto E, Arrigo T. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2014;16:378-400
34. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88
35. Miravitlles M, Soriano JB, Ancochea J, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, García-Río F. Characterisation of the overlap COPD-asthma phenotype: focus on physical activity and health status. Respir Med 2013;107:1053-1060
36. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpeläinen M, Kinnula VL, Haahtela T, Laitinen T. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011;48:279-285
37. Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008;134:14-19
38. Andersson F, Borg S, Jansson S-A, Jonsson A-C, Ericsson A, Prütz C, Rönmark E, Lundbäck B. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002;96: 700-708
39. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2000;118:1278-1285
40. Pleasants RA, Ohar JA, Croft JB, Liu Y, Kraft M, Mannino DM, Donohue JF, Herrick HL. Chronic obstructive pulmonary disease and asthmapatient characteristics and health impairment. COPD 2014;11: 256-266
41. Lin I-P, Wu S-C, Huang S-T. continuity of care and avoidable hospitalizations for chronic obstructive pulmonary disease (COPD). J Am Board Fam Med 2015;28:222-230
42. Gill JM, Mainous AG. The role of provider continuity in preventing hospitalizations. Arch Fam Med 1998;7:352-357
43. Mehta AJ, Schindler C, Perez L, Probst-Hensch N, Schwartz J, Brändl O, Karrer W, Tschopp JM, Rochat T, Künzli N; SAPALDIA Team. Acute respiratory health effects of urban air pollutants in adults with different patterns of underlying respiratory disease. Swiss Med Wkly 2012;142:w13681
44. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009;374:733-743
45. Golpe R, Sanjuán López P, Cano Jiménez E, Castro Añón O, Pérez de Llano LA. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol 2014;50:318-324
46. Oh SS, Tcheurekdjian H, Roth LA, Nguyen EA, Sen S, Galanter JM, Davis A, Farber HJ, Gilliland FD, Kumar R, et al. Effect of secondhand smoke on asthma control among black and Latino children. J Allergy Clin Immunol 2012;129:1478-1483.e7
47. Prieto-Centurion V, Rolle AJ, Au DH, Carson SS, Henderson AG, Lee TA, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, et al.; CONCERT Consortium. Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;190: 989-995
48. Ghattas C, Dai A, Gemmel DJ, Awad MH. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population. Int J Chron Obstruct Pulmon Dis 2013;8:545-549
49. Barr RG, Herbstman J, Speizer FE, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 2002;155:965-971
50. Radeos MS, Cydulka RK, Rowe BH, Barr RG, Clark S, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease among patients in the ED. Am J Emerg Med 2009;27: 191-196
51. Murgia N, Brisman J, Claesson A, Muzi G, Olin A-C, Torén K. Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulm Med 2014; 14:49